Miami Injections is your Sweetwater FL 33174 source for Tirzepatide — the dual GLP-1 + GIP molecule in Mounjaro and Zepbound. Average ~20.9% body weight loss in clinical trials. From $399/month.
Tirzepatide is the first and only dual GIP/GLP-1 receptor agonist. By activating both receptors simultaneously, it delivers synergistic metabolic effects that single-receptor GLP-1 medications cannot match.
SURMOUNT-1 Clinical Trial Result
average body weight reduction over 72 weeks at maximum dose (15mg/week)
For a Sweetwater patient weighing 200 lbs: ~42 lbs of potential weight loss
"I tried Semaglutide for 3 months but plateaued. Switched to Tirzepatide at this clinic and lost 47 lbs total. The dual mechanism makes a real difference. The staff was patient in explaining why and when to switch treatments."
Roberto A.
Sweetwater FL 33174 · Tirzepatide
"I have type 2 diabetes and my doctor recommended GLP-1 therapy. Found this clinic literally walking distance from my home. Tirzepatide has brought my A1C from 8.1 to 5.9 in 4 months. Incredible results."
Sandra V.
SW 87th Ave corridor · Tirzepatide
"Brand-name Zepbound was $1,100/month with my insurance. This clinic charges $399/month for the same active ingredient. Quality is identical — the savings allowed me to actually stay on treatment long-term."
Michael T.
Sweetwater, Miami · Tirzepatide
Our clinic is at 917 SW 87th Ave, Sweetwater FL 33174 — right in your neighborhood. We offer physician-supervised Tirzepatide (the same molecule as Mounjaro and Zepbound), Semaglutide, and B12 lipotropic injections.
Tirzepatide activates two receptors — GLP-1 and GIP — vs Semaglutide's one. This dual action produces ~20.9% average body weight loss (SURMOUNT-1 trial) vs ~14.9% for Semaglutide (STEP-1). For a 200-lb Sweetwater patient, that's potentially 40+ lbs vs ~30 lbs. Tirzepatide tends to produce more weight loss; Semaglutide has longer real-world safety data. Our physicians help you choose.
Tirzepatide programs start at $399/month at our Sweetwater clinic — a fraction of the $1,000+ cost of brand-name Mounjaro or Zepbound. Our compounded Tirzepatide contains the same active ingredient at clinically equivalent doses, prescribed and supervised by licensed Florida physicians.
Yes — Tirzepatide was originally approved as Mounjaro for type 2 diabetes before its approval as Zepbound for weight loss. It's highly effective for patients with T2D, improving both weight and glycemic control. Our Sweetwater physicians will review your diabetes medications and coordinate dosing adjustments as needed.
Tirzepatide starts at 2.5mg/week and escalates every 4 weeks: 2.5 → 5 → 7.5 → 10 → 12.5 → 15mg. Gradual escalation minimizes nausea and GI side effects. Most patients reach their optimal maintenance dose between 5-10mg. Our Sweetwater physicians adjust your dose based on your response and tolerability.
Yes. Many patients who plateau on Semaglutide switch to Tirzepatide at our clinic. The transition is medically supervised with appropriate wash-out guidance. Tirzepatide's dual mechanism often produces renewed weight loss for patients who have stalled on GLP-1 monotherapy.
Physician-supervised dual GLP-1 + GIP programs from $399/month. Your neighborhood weight loss clinic.